UBS Group
INGN icon

UBS Group’s Inogen INGN Stock Holding History

UBS Group’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-94,000
Closed -$8.96M – 7995
2019
Q1 		$8.96M Buy
+94,000
New +$11.7M ﹤0.01% 1762

Other funds holding INGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's INGN Position: Q1 2026 in Review

UBS Group increased its Inogen (INGN) stake by 139% in Q1 2026, buying an estimated $662K and bringing the position to 184,509 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #5454.

UBS Group first reported a position in INGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $8.96M in Q4 2018. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • UBS Group held 184,509 shares of Inogen worth $1.14M as of Q1 2026.
  • UBS Group bought 107,227 Inogen shares in Q1 2026, an estimated $662K.
  • Inogen made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5454 holding.
  • UBS Group first reported a position in Inogen in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Inogen position peaked at $8.96M in Q4 2018.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.